Skip to main content
. 2021 Mar 1;25(2):162–165. doi: 10.4103/jisp.jisp_189_20

Figure 5.

Figure 5

Sclerotherapy procedure (a) Slow injection of 0.2–0.5 mL of 3% sodium tetradecyl sulfate solution into the base of the lesion by insulin syringe, (b) Note the multiple sites of injection administration, (c) Occlusal view showing leaking of solution from the surface of the lesion